Cargando…

A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability

BACKGROUND: Cardiovascular disease is the leading cause of death in the United States (US). Despite the well-recognized efficacy of statins, statin discontinuation rates remain high. Statin intolerance is a major cause of statin discontinuation. To accurately diagnose statin intolerance, healthcare...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Weidan, Li, Lang, Mathur, Puneet, Thompson, John, Milks, M. Wesley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357764/
https://www.ncbi.nlm.nih.gov/pubmed/37468892
http://dx.doi.org/10.1186/s12911-023-02221-4
_version_ 1785075565089259520
author Cao, Weidan
Li, Lang
Mathur, Puneet
Thompson, John
Milks, M. Wesley
author_facet Cao, Weidan
Li, Lang
Mathur, Puneet
Thompson, John
Milks, M. Wesley
author_sort Cao, Weidan
collection PubMed
description BACKGROUND: Cardiovascular disease is the leading cause of death in the United States (US). Despite the well-recognized efficacy of statins, statin discontinuation rates remain high. Statin intolerance is a major cause of statin discontinuation. To accurately diagnose statin intolerance, healthcare professionals must distinguish between statin-associated and non-statin-associated muscle symptoms, because many muscle symptoms can be unrelated to statin therapy. Patients’ feedback on muscle-related symptoms would help providers make decisions about statin treatment. Given the potential benefits and feasibility of existing apps for cardiovascular disease (CVD) management and the unmet need for an app specifically addressing statin intolerance management, the objectives of the study were 1) to describe the developmental process of a novel app designed for patients who are eligible for statin therapy to lower the risk of CVD; 2) to explore healthcare providers’ feedback of the app; and 3) to explore patients’ app usage experience. METHODS: The app was developed by an interdisciplinary team. Healthcare provider participants and patient participants were recruited in the study. Providers were interviewed to provide their feedback about the app based on screenshots of the app. Patients were interviewed after a 30 days of app usage. RESULTS: The basic features of the app included symptom logging, vitals tracking, patient education, and push notifications. Overall, both parties provided positive feedback about the app. Areas to be improved mentioned by both parties included: the pain question asked in symptom tracking and the patient education section. Both parties agreed that it was essential to add the trend report of the logged symptoms. CONCLUSIONS: The results indicated that providers were willing to use patient-reported data for disease management and perceived that the app had the potential to facilitate doctor-patient communication. Results also indicated that user engagement is the key to the success of app efficacy. To promote app engagement, app features should be tailored to individual patient’s needs and goals. In the future, after it is upgraded, we plan to test the app usability and feasibility among a more diverse sample. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-023-02221-4.
format Online
Article
Text
id pubmed-10357764
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103577642023-07-21 A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability Cao, Weidan Li, Lang Mathur, Puneet Thompson, John Milks, M. Wesley BMC Med Inform Decis Mak Research BACKGROUND: Cardiovascular disease is the leading cause of death in the United States (US). Despite the well-recognized efficacy of statins, statin discontinuation rates remain high. Statin intolerance is a major cause of statin discontinuation. To accurately diagnose statin intolerance, healthcare professionals must distinguish between statin-associated and non-statin-associated muscle symptoms, because many muscle symptoms can be unrelated to statin therapy. Patients’ feedback on muscle-related symptoms would help providers make decisions about statin treatment. Given the potential benefits and feasibility of existing apps for cardiovascular disease (CVD) management and the unmet need for an app specifically addressing statin intolerance management, the objectives of the study were 1) to describe the developmental process of a novel app designed for patients who are eligible for statin therapy to lower the risk of CVD; 2) to explore healthcare providers’ feedback of the app; and 3) to explore patients’ app usage experience. METHODS: The app was developed by an interdisciplinary team. Healthcare provider participants and patient participants were recruited in the study. Providers were interviewed to provide their feedback about the app based on screenshots of the app. Patients were interviewed after a 30 days of app usage. RESULTS: The basic features of the app included symptom logging, vitals tracking, patient education, and push notifications. Overall, both parties provided positive feedback about the app. Areas to be improved mentioned by both parties included: the pain question asked in symptom tracking and the patient education section. Both parties agreed that it was essential to add the trend report of the logged symptoms. CONCLUSIONS: The results indicated that providers were willing to use patient-reported data for disease management and perceived that the app had the potential to facilitate doctor-patient communication. Results also indicated that user engagement is the key to the success of app efficacy. To promote app engagement, app features should be tailored to individual patient’s needs and goals. In the future, after it is upgraded, we plan to test the app usability and feasibility among a more diverse sample. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-023-02221-4. BioMed Central 2023-07-19 /pmc/articles/PMC10357764/ /pubmed/37468892 http://dx.doi.org/10.1186/s12911-023-02221-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cao, Weidan
Li, Lang
Mathur, Puneet
Thompson, John
Milks, M. Wesley
A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability
title A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability
title_full A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability
title_fullStr A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability
title_full_unstemmed A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability
title_short A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability
title_sort mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357764/
https://www.ncbi.nlm.nih.gov/pubmed/37468892
http://dx.doi.org/10.1186/s12911-023-02221-4
work_keys_str_mv AT caoweidan amobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT lilang amobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT mathurpuneet amobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT thompsonjohn amobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT milksmwesley amobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT caoweidan mobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT lilang mobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT mathurpuneet mobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT thompsonjohn mobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability
AT milksmwesley mobilehealthapplicationforpatientseligibleforstatintherapyappdevelopmentandqualitativefeedbackondesignandusability